HB Ad Slot
HB Mobile Ad Slot
First Patent to Survive Post Grant Review
Wednesday, November 16, 2016

Congratulations to Paragon BioTeck Inc.  Its US Patent No. 8,859,623 has survived a post grant review challenge brought by Altaire Pharmaceuticals.  In only its 4th written decision, the PTAB found that Altaire did not prove that the Paragon patent claims were invalid as obvious in light of Altaire's earlier products. 

Altaire Pharmaceuticals Inc. v. Paragon BioTeck Inc., PGR2015-00011

HB Ad Slot
HB Ad Slot
HB Mobile Ad Slot
HB Ad Slot
HB Mobile Ad Slot
 
NLR Logo
We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up to receive our free e-Newsbulletins

 

Sign Up for e-NewsBulletins